Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-058761

Chief Product & Tech Officer gave up 4,079 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product & Tech Officer 2025-12-23 Shares withheld for taxes −4,079 $12.74 $51,966 66,876 D
Loading xslF345X05/wk-form4_1766526792.xml…